Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Claris Bio, headquartered in Jersey City, NJ, is a late-clinical stage biotechnology company specializing in corneal disease therapies. The company has devised a topical formulation technology tailored for the treatment of corneal wounds, ulcers, and scars in patients. Leveraging its technology, Claris Bio produces a recombinant hepatocyte growth factor, which serves to expedite the healing process. This innovative approach pr...
Claris Bio, headquartered in Jersey City, NJ, is a late-clinical stage biotechnology company specializing in corneal disease therapies. The company has devised a topical formulation technology tailored for the treatment of corneal wounds, ulcers, and scars in patients. Leveraging its technology, Claris Bio produces a recombinant hepatocyte growth factor, which serves to expedite the healing process. This innovative approach provides healthcare professionals with a noninvasive therapeutic treatment option, allowing patients to achieve faster recovery and maintain their overall well-being.

List your booth number for exhibitions, ask us